Oakworth Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Oakworth Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$239K	Buy	1,524 +377	+33%	+$51K	0.01%	238
2026 Q1	$147K	Sell	1,147 -37	-3%	-$4.62K	0.01%	294
2025 Q4	$144K	Sell	1,184 -6	-0.5%	-$688	0.01%	291
2025 Q3	$119K	Sell	1,190 -236	-17%	-$21.3K	0.01%	314
2025 Q2	$118K	Sell	1,426 -2,803	-66%	-$224K	0.01%	270
2025 Q1	$343K	Sell	4,229 -1,463	-26%	-$131K	0.02%	152
2024 Q4	$513K	Sell	5,692 -271	-5%	-$26.3K	0.04%	122
2024 Q3	$589K	Buy	5,963 +242	+4%	+$23.8K	0.04%	113
2024 Q2	$530K	Sell	5,721 -154,812	-96%	-$13.9M	0.04%	117
2024 Q1	$15.2M	Sell	160,533 -4,541	-3%	-$421K	1.15%	23
2023 Q4	$14.7M	Buy	165,074 +2,563	+2%	+$190K	1.18%	20
2023 Q3	$11.9M	Sell	162,511 -8,582	-5%	-$686K	1.08%	22
2023 Q2	$14.2M	Sell	171,093 -286	-0.2%	-$23.9K	1.21%	21
2023 Q1	$13.1M	Buy	171,379 +1,075	+0.6%	+$89.2K	1.17%	23
2022 Q4	$14.1M	Sell	170,304 -2,858	-2%	-$231K	1.36%	18
2022 Q3	$13.7M	Buy	173,162 +853	+0.5%	+$71.9K	1.52%	17
2022 Q2	$12.8M	Buy	+172,309	New	+$12.9M	1.29%	19
2019 Q4	–	Sell	-210	Closed	-$16K	–	585
2019 Q3	$16K	Hold	210	–	–	﹤0.01%	401
2019 Q2	$18K	Hold	210	–	–	﹤0.01%	438
2019 Q1	$19K	Hold	210	–	–	﹤0.01%	396
2018 Q4	$15K	Hold	210	–	–	﹤0.01%	407
2018 Q3	$20K	Hold	210	–	–	﹤0.01%	393
2018 Q2	$20K	Hold	210	–	–	﹤0.01%	396
2018 Q1	$18K	Hold	210	–	–	﹤0.01%	383
2017 Q4	$17K	Buy	+210	New	+$17.6K	﹤0.01%	403

Other funds holding XBI

PSP Research Newtown Square, Pennsylvania $188M AUM

Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

RFM

Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

NHFG

New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return

MFS

Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return

LRPA

L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return

WTC

WhitTier Trust Company Reno, Nevada $5.35B AUM 29.91% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return

Oakworth Capital's XBI Position: Q2 2026 in Review

Oakworth Capital increased its State Street SPDR S&P Biotech ETF (XBI) stake by 33% in Q2 2026, buying an estimated $51K and bringing the position to 1,524 shares worth $239K. The position accounts for 0.01% of the portfolio, ranked #238.

Oakworth Capital first reported a position in XBI in Q4 2017 and has held it in 25 quarters since. The position peaked at $15.2M in Q1 2024. 321 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Oakworth Capital held 1,524 shares of State Street SPDR S&P Biotech ETF worth $239K as of Q2 2026.
Oakworth Capital bought 377 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $51K.
State Street SPDR S&P Biotech ETF made up 0.01% of Oakworth Capital's portfolio in Q2 2026, its #238 holding.
Oakworth Capital first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and has held it in 25 quarters since.
Oakworth Capital's State Street SPDR S&P Biotech ETF position peaked at $15.2M in Q1 2024.
321 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.